SERNOVA BIOTHERAPEUTICS INC (PSH0.DE) Stock Balance Sheet
FRA:PSH0 - Deutsche Boerse Ag - CA81752F1062 - Common Stock - Currency: EUR
| MRQ (2025-1-31) | 2024 (2024-10-31) | 2023 (2023-10-31) | 2022 (2022-10-31) | 2021 (2021-10-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 1.21M | 6.01M | 8.72M | 3.78M | 27.87M | |||
| Marketable Securities | N/A | 0.00 | 11.08M | 46.00M | N/A | |||
| Receivables | 373.30K | 298.10K | 1.05M | 1.15M | 449.00K | |||
| Other Current Assets | 487.40K | 159.20K | 164.70K | 168.00K | 4.20K | |||
| Total Current Assets | 2.07M | 6.47M | 21.02M | 51.09M | 28.33M | |||
| Non-Current Assets | ||||||||
| PPE Net | 786.30K | 833.90K | 507.40K | 653.70K | 564.70K | |||
| Intangibles | N/A | 0.00 | 316.70K | 516.80K | 716.80K | |||
| Other Non-Current Assets | 223.90K | 223.90K | 259.20K | 223.90K | 211.60K | |||
| Total Non-Current Assets | 1.01M | 1.06M | 1.08M | 1.39M | 1.49M | |||
| TOTAL ASSETS | 3.08M | 7.53M | 22.11M | 52.48M | 29.82M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 106.20K | 101.50K | 136.10K | 139.90K | 117.40K | |||
| Accrued Expenses | N/A | 1.75M | 1.85M | 700.50K | 691.20K | |||
| Accounts Payable | 20.46M | 17.24M | 6.85M | 3.61M | 449.40K | |||
| Other Current Liabilities | N/A | 919.70K | 757.30K | 286.40K | 217.90K | |||
| Total Current Liabilities | 20.57M | 20.02M | 9.59M | 4.74M | 1.48M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 440.30K | 468.50K | 0.00 | 136.10K | 276.00K | |||
| Total Non-Current Liabilities | 440.30K | 468.50K | 0.00 | 136.20K | 276.00K | |||
| TOTAL LIABILITIES | 21.01M | 20.48M | 9.59M | 4.88M | 1.75M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -156.02M | -150.32M | -118.17M | -75.87M | -51.06M | |||
| Additional Paid In Capital | 20.03M | 20.69M | 19.69M | 12.49M | 5.11M | |||
| Common Shares | 118.06M | 116.68M | 110.99M | 110.99M | 74.01M | |||
| Shares Outstanding | 328.48M | 325.32M | 303.33M | 303.33M | 261.13M | |||
| Tangible Book Value per Share | -0.05 | -0.04 | 0.04 | 0.16 | 0.10 | |||
| Total Shareholders' Equity | -17.93M | -12.96M | 12.51M | 47.61M | 28.07M | |||
| TOTAL LIABILITIES AND EQUITY | 3.08M | 7.53M | 22.11M | 52.48M | 29.82M | |||
| Statistics | ||||||||
| Debt/Equity | -0.02 | -0.04 | N/A | 0.00 | 0.01 | |||
| Current Ratio | 0.10 | 0.32 | 2.19 | 10.78 | 19.19 | |||
| Return On Assets (ROA) | -914.25% | -427.67% | -176.40% | -46.53% | -23.36% | |||
| Return On Equity (ROE) | N/A | N/A | -311.62% | -51.29% | -24.82% | |||
All data in CAD , ROIC based on taxRate of 0.30